Literature DB >> 33817153

Risk Factors of Regional Lymph Node Metastasis in Patients with Cervical Cancer.

Chunchun Wu1, Lichun Li1, Xue Xiao2, Anyi Sun3, Wenji Lin4, Ailu Li5.   

Abstract

OBJECTIVES: To explore the risk factors related to regional lymph node metastasis in cervical cancer and analyze the value of independent risk factors in predicting regional lymph node metastasis.
METHODS: We retrospectively analyzed the clinical data of 699 patients who underwent surgery for stage IB1-IIA2 cervical cancer in Quanzhou First Hospital affiliated to Fujian Medical University from 2010 to 2016. The patients were divided into metastasis (n = 92) and non-metastasis (n = 607) groups based on the postoperative pathology of regional lymph node status. The relevant clinicopathological features of the metastasis and non-metastasis groups were compared through variance analysis and chi-square tests. Logistic regression was adopted to screen relevant independent risk factors of regional lymph node metastasis.
RESULTS: In univariate analysis, International Federation of Gynecology and Obstetrics (FIGO) stages, serum squamous cell carcinoma antigen (SCC-Ag), histological type of squamous carcinoma and maximal tumor diameter were related factors for lymphatic metastasis in patients with cervical cancer. In multivariate analysis, SCC-Ag and histological type of squamous carcinoma were independent prognostic factors for lymphatic metastasis in patients with cervical cancer. Pre-treatment SCC-Ag serum levels, as a predictor of lymph node metastasis of cervical cancer, revealed a sensitivity of 62.07% (95% confidence interval (CI): 51.03-72.62%), specificity of 65.15% (59.07-70.89%), and area under the receiver operating characteristic (ROC) curve of 0.69 (95% CI: 0.61-0.76).
CONCLUSIONS: Cervical cancer patients whose pathological type is squamous carcinoma with high levels of SSC-Ag pre-operation are more likely to be diagnosed with regional lymph node metastasis. Standardized lymph node dissection should be implemented during operation.
© 2019 Chunchun Wu et al., published by De Gruyter.

Entities:  

Keywords:  cervical cancer; logistic regression; lymph node metastasis; prognosis; risk factors

Year:  2019        PMID: 33817153      PMCID: PMC7874751          DOI: 10.1515/biol-2019-0023

Source DB:  PubMed          Journal:  Open Life Sci        ISSN: 2391-5412            Impact factor:   0.938


  16 in total

1.  Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.

Authors:  T Kamura; T Shigematsu; T Kaku; T Shimamoto; T Saito; K Sakai; M Mitsumoto; H Nakano
Journal:  Acta Obstet Gynecol Scand       Date:  1999-05       Impact factor: 3.636

Review 2.  Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer.

Authors:  Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

Review 3.  Adenocarcinoma: a unique cervical cancer.

Authors:  Lilian T Gien; Marie-Claude Beauchemin; Gillian Thomas
Journal:  Gynecol Oncol       Date:  2009-10-31       Impact factor: 5.482

4.  Pretreatment levels of serum squamous cell carcinoma antigen and urine polyamines in women with squamous cell carcinoma of the cervix.

Authors:  Y T Kim; B S Yoon; J W Kim; S H Kim; J Y Kwon; J H Kim
Journal:  Int J Gynaecol Obstet       Date:  2005-10       Impact factor: 3.561

5.  Relationship between lymph node metastases and histopathological parameters in carcinoma cervix: a multivariate analysis.

Authors:  V R Pallavi; K U Devi; G Mukherjee; C Ramesh; U D Bafna
Journal:  J Obstet Gynaecol       Date:  2012-01       Impact factor: 1.246

6.  Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging.

Authors:  Kiyoshi Ohara; Yumiko Tanaka; Hajime Tsunoda; Masato Nishida; Shinji Sugahara; Yuji Itai
Journal:  Obstet Gynecol       Date:  2002-10       Impact factor: 7.661

Review 7.  Cervical cancer - State of the science: From angiogenesis blockade to checkpoint inhibition.

Authors:  Lindsey E Minion; Krishnansu S Tewari
Journal:  Gynecol Oncol       Date:  2018-02-03       Impact factor: 5.482

Review 8.  Different strategies of treatment for uterine cervical carcinoma stage IB2-IIB.

Authors:  Lucas Minig; María Guadalupe Patrono; Nuria Romero; Juan Francisco Rodríguez Moreno; Jesús Garcia-Donas
Journal:  World J Clin Oncol       Date:  2014-05-10

Review 9.  Can We Be Less Radical with Surgery for Early Cervical Cancer?

Authors:  Madeleine C Macdonald; John A Tidy
Journal:  Curr Oncol Rep       Date:  2016-03       Impact factor: 5.075

Review 10.  Clinical statistics of gynecologic cancers in Japan.

Authors:  Wataru Yamagami; Satoru Nagase; Fumiaki Takahashi; Kazuhiko Ino; Toru Hachisuga; Daisuke Aoki; Hidetaka Katabuchi
Journal:  J Gynecol Oncol       Date:  2017-02-10       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.